Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 1752289)

Published in Eur J Clin Invest on October 01, 1991

Authors

R T Cunningham1, I S Young, J Winder, M J O'Kane, S McKinstry, C F Johnston, O M Dolan, S A Hawkins, K D Buchanan

Author Affiliations

1: Department of Medicine, Queen's University of Belfast.

Articles by these authors

The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM (1996) 3.31

Obesity and the lung: 1. Epidemiology. Thorax (2008) 2.08

Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet Rec (1998) 2.05

Clinical studies of multiple endocrine neoplasia type 1 (MEN1) QJM (1996) 1.93

An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology (1998) 1.72

Structural features of the colony-stimulating factor 1 receptor that affect its association with phosphatidylinositol 3-kinase. EMBO J (1990) 1.72

Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin. Gut (1983) 1.71

New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet (1997) 1.70

Neonatal secretion of gastrin and glucagon. Arch Dis Child (1974) 1.70

Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study. Diabetes Care (1997) 1.64

Oral inoculation of sheep with the agent of bovine spongiform encephalopathy (BSE). 1. Onset and distribution of disease-specific PrP accumulation in brain and viscera. J Comp Pathol (2001) 1.60

Hypercalcaemia in rheumatoid arthritis: investigation of its causes and implications. Ann Rheum Dis (1979) 1.58

Carbamylation of proteins and atherogenesis in renal failure. Med Hypotheses (1995) 1.57

Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial-design, controlled trial. Am J Clin Nutr (1998) 1.56

The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis (2001) 1.53

Plasma glutathione peroxidase activity is reduced in haemodialysis patients. Nephron (1999) 1.51

Overexpression of the tumour suppressor gene p53 is not implicated in neuroendocrine tumour carcinogenesis. J Pathol (1995) 1.50

Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course. Mult Scler (2004) 1.45

Neuropeptide variability in man. Eur J Clin Invest (2000) 1.45

Effect of Helicobacter pylori eradication on antral somatostatin cell density in humans. Eur J Gastroenterol Hepatol (1998) 1.45

On the antioxidant properties of erythropoietin and its association with the oxidative-nitrosative stress response to hypoxia in humans. Acta Physiol (Oxf) (2014) 1.43

Implications of attendance patterns in Northern Ireland for abdominal aortic aneurysm screening. Eur J Vasc Endovasc Surg (2011) 1.42

Brisk walking, fitness, and cardiovascular risk: a randomized controlled trial in primary care. Prev Med (2005) 1.41

An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis. J Neurol Sci (2000) 1.40

Changing patterns in presentation and management of the Zollinger-Ellison syndrome in Northern Ireland, 1970-1988. Q J Med (1991) 1.39

Anaesthesia for magnetic resonance imaging: a survey of current practice in the UK and Ireland. Anaesthesia (2000) 1.39

Is the secretion of atrial natriuretic peptide in man under neural control? Eur Heart J (2000) 1.39

Evaluation of a novel 'needlecatcher' surgical instrument designed to reduce the incidence of needle stick injuries from suture needles during skin suturing. Br J Dermatol (2008) 1.38

Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem (1995) 1.37

Evaluation of the status of canine hydrotherapy in the UK. Vet Rec (2011) 1.37

Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol (1999) 1.30

Neuroendocrine tumors. A European view. Am J Med (1986) 1.29

Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology (2007) 1.27

Investigating the palliative efficacy of whole-brain radiotherapy for patients with multiple-brain metastases and poor prognostic features. Clin Oncol (R Coll Radiol) (2003) 1.26

Stimulation of gastrin release by catecholamines. Lancet (1972) 1.26

The frequency of gastrointestinal endocrine tumours in a well-defined population--Northern Ireland 1970-1985. Q J Med (1989) 1.25

Improvement of in-rumen digestibility of alfalfa forage by genetic manipulation of lignin O-methyltransferases. Transgenic Res (2001) 1.24

Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging. QJM (1998) 1.23

Total antioxidant capacity of seminal plasma is different in fertile and infertile men. Fertil Steril (1995) 1.22

Enzymic iodination of the histidyl residue of secretin: a radioimmunoassay of the hormone. Biochim Biophys Acta (1973) 1.20

Transient release of lipid peroxides after coronary artery balloon angioplasty. Lancet (1990) 1.20

Comparing patient-generated blood glucose diary records with meter memory in diabetes: a systematic review. Diabet Med (2013) 1.18

Infectivity in the ileum of cattle challenged orally with bovine spongiform encephalopathy. Vet Rec (1994) 1.18

Respiratory acidosis in hypothermic myxoedema coma. Postgrad Med J (1967) 1.17

The quest for the inhibitory neurotransmitter in bovine tracheal smooth muscle. Q J Exp Physiol (1983) 1.16

Mechanical properties of tendons: changes with sterilization and preservation. J Biomech Eng (1996) 1.15

Maturity onset diabetes mellitus: response to intensive dietary management. Br Med J (1975) 1.13

Neuron-specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg (1996) 1.13

Techniques, usefulness, and hazards of arteriography of pheochromocytoma. Review of 99 cases. JAMA (1968) 1.13

Identification of lesion components that influence visual function in age related macular degeneration. Br J Ophthalmol (2003) 1.12

Reperfusion injury is greater with delayed restoration of venous outflow in concurrent arterial and venous limb injury. Br J Surg (2000) 1.12

Altered free radical metabolism in acute mountain sickness: implications for dynamic cerebral autoregulation and blood-brain barrier function. J Physiol (2008) 1.11

Triglyceride metabolism in acute starvation: the role of secretin and glucagon. Eur J Clin Invest (1976) 1.10

Abnormalities of glucagon metabolism in untreated diabetes mellitus. Lancet (1972) 1.10

Effect of blood glucose on glucagon secretion in anesthetized dogs. Diabetes (1969) 1.09

Hypergastrinaemia in rheumatoid arthritis: disease or iatrogenesis. Br Med J (1973) 1.08

Comparison of individual antioxidants of sperm and seminal plasma in fertile and infertile men. Fertil Steril (1997) 1.08

The normal insulin response to glucose. The relationship between blood sugar and plasma insulin. Diabetologia (1967) 1.08

Electron spin resonance spectroscopy, exercise, and oxidative stress: an ascorbic acid intervention study. J Appl Physiol (1985) (1999) 1.08

Pancreatic glucagon release and sulphonylureas. Lancet (1969) 1.07

Treatment of hypophosphataemia. Lancet (1993) 1.07

Carcinoma of the bronchus in the Yorkshire region of England 1976-1990: trends since 1984. Eur Respir J (1997) 1.07

Skin cancer trends in Northern Ireland and consequences for provision of dermatology services. Br J Dermatol (2007) 1.07

Cimetidine for duodenal ulceration in patients undergoing haemodialysis. Br Med J (1977) 1.07

Carbohydrate metabolism in duodenal ulcer patients. Gut (1967) 1.07

Nicorandil-associated perianal ulceration: a case series of 10 patients. Br J Dermatol (2006) 1.07

Vasectomy, vas ligation and vas occlusion. Urology (1973) 1.06

Second primary cancers in patients with skin cancer: a population-based study in Northern Ireland. Br J Cancer (2009) 1.06

A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry (1989) 1.06

Animal model to study the relationship between immunoreactive gastrin and inflammatory arthritis. Nature (1974) 1.06

Insulin control of glucagon release from insulin-deficient rat islets. Diabetes (1973) 1.05

Traumatic Brown-Séquard-plus syndrome. Arch Neurol (2001) 1.05

Association of diabetes with age-related macular degeneration in the EUREYE study. Br J Ophthalmol (2009) 1.04

A glycoside-hydrolase inhibitor in treatment of dumping syndrome. Lancet (1979) 1.02

Mutation screening and genotype:phenotype correlation in familial hypercholesterolaemia. Atherosclerosis (1999) 1.02

Glucagonoma syndrome demonstrating giant duodenal villi. Gut (1984) 1.02

Secretin: A new role for an old hormone. Lancet (1975) 1.02

Electron spin resonance spectroscopic detection of oxygen-centred radicals in human serum following exhaustive exercise. Eur J Appl Physiol Occup Physiol (1998) 1.01

Erythropoietin production in kidney tubular cells. Br J Haematol (1990) 1.00

Isolation of glucagon-like immunoreactivity of gut by affinity chromatography on anti-glucagon antibodies coupled to sepharose 4 B. Biochim Biophys Acta (1973) 1.00

Triamcinolone acetonide Aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: a placebo-controlled, double-blind study. Clin Ther (1995) 1.00

Relationship between physiological loss, performance decrement, and age in master athletes. J Gerontol A Biol Sci Med Sci (2001) 1.00

Familial nesidioblastosis as the predominant manifestation of multiple endocrine adenomatosis. Am J Med (1972) 1.00

Oxidative stress in lavage fluid of preterm infants at risk of chronic lung disease. Am J Physiol Lung Cell Mol Physiol (2001) 0.99

Insulin and glucagon responses in subjects with pheochromocytoma: effect of alpha adrenergic blockade. J Clin Endocrinol Metab (1969) 0.99

Serum neurone-specific enolase as an indicator of stroke volume. Eur J Clin Invest (1996) 0.99

A double antibody immunoassay for glucagon. Diabetes (1968) 0.99

Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis. Arch Neurol (1987) 0.98

Glucagon clearance by the isolated perfused rat liver. Proc Soc Exp Biol Med (1968) 0.98

Determination of thiamine by high-performance liquid chromatography. J Chromatogr A (2000) 0.98